These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13295664)

  • 21. An immune anti-M iso-agglutinin in human serum.
    WALSH RJ
    Med J Aust; 1946 Jan; 1():115. PubMed ID: 21013747
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the agglutination of tuberculine coated red cells.
    MILGROM F; SWIERCZYNSKA Z
    Schweiz Z Pathol Bakteriol; 1955; 18(3):257-69. PubMed ID: 13255857
    [No Abstract]   [Full Text] [Related]  

  • 23. A method of quantitative differential agglutination of dog erythrocytes.
    SWISHER SN; IZZO MJ; YOUNG LE
    J Lab Clin Med; 1953 Jun; 41(6):936-45. PubMed ID: 13061819
    [No Abstract]   [Full Text] [Related]  

  • 24. The reversed BDB technique. The agglutination of antibody-coated red blood cells by homologous antigen.
    CUA-LIM F; RICHTER M; ROSE B
    J Allergy; 1963; 34():142-54. PubMed ID: 14024149
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of the agglutinating properties of several strains of ECHO virus in presence of human erythrocytes of various blood groups and erythrocytes of various animal species].
    MARINESCU G; SORODOC G; SARATEANU D; DUMITRESCU S
    Stud Cercet Inframicrobiol; 1961; 12(Suppl)():215-21. PubMed ID: 14469872
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of differential red cell agglutination utilizing an electronic particle counter.
    Greendyke RM; Bowdler AJ; Swisher SN
    Am J Clin Pathol; 1969 Jan; 51(1):24-9. PubMed ID: 5812787
    [No Abstract]   [Full Text] [Related]  

  • 27. [3 "B WEAK" PHENOTYPES: B80, B60, B0, DEFINED BY THEIR AGGLUTINABILITY AS COMPARED TO THAT OF THE "B100" NORMAL PHENOTYPE].
    SALMON C; REVIRON J
    Nouv Rev Fr Hematol; 1964; 4():655-67. PubMed ID: 14199495
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of differential red cell agglutination utilizing an electronic particle counter. II. Simultaneous determination of red cell survival by cr 51 tagging and differential agglutination.
    Greendyke RM; Knoll PJ; Swisher SN
    Am J Clin Pathol; 1969 Jan; 51(1):30-4. PubMed ID: 5250185
    [No Abstract]   [Full Text] [Related]  

  • 29. MAGNETIC FIELD EFFECTS ON ERYTHROCYTE AGGLUTINATION.
    HACKEL E
    Vox Sang; 1964; 9():60-4. PubMed ID: 14115408
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of red cell agglutination in viscous media containing synthetic substances.
    Matsuzawa S
    Nihon Hoigaku Zasshi; 1967 Mar; 21(2):204-9. PubMed ID: 5624420
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of erythrocyte survival curves obtained simultaneously by 51Cr and an automated differential agglutination technic.
    Szymanski IO; Valeri CR
    Transfusion; 1970; 10(6):287-98. PubMed ID: 5490095
    [No Abstract]   [Full Text] [Related]  

  • 32. [Injury and spherical modifications of erythrocytes in hemagglutination].
    TOMCSIK J; SCHILD CA
    Experientia; 1950 Nov; 6(11):422-3. PubMed ID: 14793535
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of weather factors on titer value and spontaneous agglutination in the collidon conglutination test, and on the viscosity of collidon solutions].
    HUMMEL K; CAROLI G
    Z Hyg Infektionskr; 1952; 135(6):592-600. PubMed ID: 13039371
    [No Abstract]   [Full Text] [Related]  

  • 34. Indirect hemagglutination for the diagnosis of Heterobilharzia americana infections in dogs.
    Goff WL; Ronald NC
    Am J Vet Res; 1982 Nov; 43(11):2038-41. PubMed ID: 6217768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcaligenes haemagglutinans: factors determining the agglutinability of the red blood cells and the mechanism of the agglutination.
    DRIMMER-HERRNHEISER H; OLITZKI AL
    Schweiz Z Pathol Bakteriol; 1958; 21(1):93-103. PubMed ID: 13555772
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of dog erythrocyte antigen 1.1 in 4 breeds native to different areas in Turkey.
    Ergul Ekiz E; Arslan M; Ozcan M; Gultekin GI; Gulay OY; Kirmizibayrak T; Giger U
    Vet Clin Pathol; 2011 Dec; 40(4):518-523. PubMed ID: 22136478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative hemagglutination inhibition studies of blood group substances. II. Characterization of anti-A isohemagglutinins by their behavior with blood group A substances.
    GIBBS MB; LAFFER NC; DUNNE CJ; AKEROYD JH
    J Immunol; 1961 Oct; 87():405-14. PubMed ID: 13898363
    [No Abstract]   [Full Text] [Related]  

  • 40. Dog erythrocyte antigen 1: mode of inheritance and initial characterization.
    Polak K; Acierno MM; Raj K; Mizukami K; Siegel DL; Giger U
    Vet Clin Pathol; 2015 Sep; 44(3):369-79. PubMed ID: 26291052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.